Quick Answer
HeartSciences Inc. reported Total Revenue of $4.4 thousand for the year ending 2025.
- HeartSciences Inc. showed a decrease of -76.6% in Total Revenue from 2024 to 2025.
- This data is from HeartSciences Inc.'s annual report (Form 10-K), filed with the SEC on July 24, 2025.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $7.5 thousand | Q1 2022: $2.7 thousand | Q3 2022: $3.2 thousand | Q1 2023: $2.0 thousand | Q4 2023: $3.9 thousand | Q1 2024: $14.7 thousand | Q1 2025: $0.00 | Q3 2025: $1.9 thousand | Q4 2025: $2.4 thousand | Q1 2026: $0.00.
- Over the full 4 years of available data (2022 to 2025), HeartSciences Inc.'s Total Revenue has declined by 69.7%.
- Historical annual values: Fiscal year 2025: $4.4 thousand | Fiscal year 2024: $18.6 thousand | Fiscal year 2023: $5.2 thousand | Fiscal year 2022: $14.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: